All In Biotech

Free tool

FAERS Monitor: Kevzara

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761037 or its brand name (Kevzara, Sarilumab). Reports on generic versions are filed under their own applications.

Reports

27,761

Serious

11,334

41% of reports

Hospitalization

4,564

Death reported

2,628

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pain6,401
  • drug ineffective6,342
  • arthralgia5,500
  • joint swelling4,778
  • rheumatoid arthritis4,773
  • condition aggravated3,892
  • fatigue3,672
  • rash3,411
  • alopecia3,134
  • abdominal discomfort3,072
  • hepatic enzyme increased2,991
  • systemic lupus erythematosus2,917
  • pemphigus2,855
  • hand deformity2,791
  • swelling2,768

Reports by year received

View as table
YearReports
201510
201615
2017138
20181,262
20191,948
20201,975
20212,986
20223,195
20232,947
20244,413
20254,892
20263,980

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,026,398 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pemphigusSignal2,855223.9215.1489,060
hand deformitySignal2,791204.5196.4445,082
systemic lupus erythematosusSignal2,91767.765.4176,313
hepatic enzyme increasedSignal2,99134.733.593,923
rheumatoid arthritisSignal4,77333.232.3143,568
joint swellingSignal4,77831.230.4134,814
swellingSignal2,76823.122.256,920
abdominal discomfortSignal3,07214.113.637,031
alopeciaSignal3,13412.311.932,216
arthralgiaSignal5,50010.19.945,622
condition aggravatedSignal3,8929.89.530,842
painSignal6,4018.07.839,749
rashSignal3,4116.05.814,286
drug ineffectiveSignal6,3423.73.613,006
fatigueSignal3,6723.63.57,073

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.